Genomic Vision (GV.PA)
FR0011799907 - Common Stock
| MRQ (2023-6-30) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash | 14.00K | 760.00K | 2.29M | 1.82M | 807.00K | |||
| Cash Equivalents | N/A | N/A | N/A | 174.00K | 275.00K | |||
| Receivables | 2.04M | 1.40M | 1.80M | 2.14M | 2.18M | |||
| Inventories | 290.00K | 1.39M | 1.17M | 1.25M | 1.34M | |||
| Other Current Assets | -1.00K | N/A | -1.00K | N/A | 54.00K | |||
| Total Current Assets | 2.34M | 3.55M | 5.26M | 5.38M | 4.65M | |||
| Non-Current Assets | ||||||||
| PPE Net | 1.23M | 1.04M | 1.27M | 1.57M | 590.00K | |||
| Investments And Advances | 363.00K | 356.00K | 184.00K | 264.00K | 248.00K | |||
| Intangibles | 23.00K | 37.00K | 62.00K | 88.00K | 114.00K | |||
| Other Non-Current Assets | 1.00K | N/A | N/A | 0.00 | N/A | |||
| Total Non-Current Assets | 1.61M | 1.44M | 1.51M | 1.93M | 952.00K | |||
| TOTAL ASSETS | 3.96M | 4.99M | 6.77M | 7.30M | 5.60M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | 197.00K | 311.00K | 178.00K | 116.00K | 108.00K | |||
| Accrued Expenses | 1.24M | 1.30M | 1.13M | 1.09M | 707.00K | |||
| Accounts Payable | 3.37M | 1.55M | 1.10M | 1.38M | 821.00K | |||
| Other Current Liabilities | 898.00K | 751.00K | 197.00K | 363.00K | 508.00K | |||
| Total Current Liabilities | 5.70M | 3.91M | 2.61M | 2.95M | 2.14M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 785.00K | 2.13M | 816.00K | 1.02M | 0.00 | |||
| Other Non-Current Liabilities | 241.00K | 241.00K | 272.00K | 214.00K | 231.00K | |||
| Total Non-Current Liabilities | 1.03M | 2.37M | 1.09M | 1.23M | 231.00K | |||
| TOTAL LIABILITIES | 6.73M | 6.28M | 3.70M | 4.18M | 2.38M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -34.45M | -29.60M | -28.01M | -25.18M | -20.04M | |||
| Additional Paid In Capital | 27.82M | 27.16M | 25.02M | 23.15M | 19.41M | |||
| Common Shares | 3.86M | 1.15M | 6.05M | 5.15M | 3.85M | |||
| Other Shareholders' Equity | N/A | -1.00K | 1.00K | -1.00K | N/A | |||
| Shares Outstanding | 385.11M | 113.69M | 60.51M | 51.46M | 38.49M | |||
| Tangible Book Value per Share | -0.01 | -0.01 | 0.05 | 0.06 | 0.08 | |||
| Total Shareholders' Equity | -2.77M | -1.29M | 3.07M | 3.12M | 3.23M | |||
| TOTAL LIABILITIES AND EQUITY | 3.96M | 4.99M | 6.77M | 7.30M | 5.60M | |||
| Statistics | ||||||||
| Debt/Equity | -0.28 | -1.65 | 0.27 | 0.33 | N/A | |||
| Current Ratio | 0.41 | 0.91 | 2.01 | 1.82 | 2.17 | |||
| Return On Assets (ROA) | -268.44% | -136.10% | -73.81% | -70.89% | -82.26% | |||
| Return On Equity (ROE) | N/A | N/A | -162.80% | -165.77% | -142.80% | |||
All data in EUR